Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inozyme Pharma

0.9842
+0.02422.52%
Post-market: 1.000.0158+1.61%18:37 EDT
Volume:256.06K
Turnover:248.66K
Market Cap:63.23M
PE:-0.61
High:0.9999
Open:0.9600
Low:0.9398
Close:0.9600
Loading ...
Apr 12, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Major Issues Report

8-K - Current report
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 08, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 19, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 11, 2021

Major Issues Report

8-K - Current report
Aug 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 24, 2021

Major Issues Report

8-K - Current report